今海医疗科技（02225）股价今日表现活跃，盘中涨幅一度超过5%。截至最新交易时段，该股上涨4.08%，报4.72港元，成交额达628.74万港元。
据近期披露的2026年中期业绩显示，公司在营收扩张与盈利质量方面均呈现积极态势。报告期内，集团实现收益3402.1万新加坡元，较去年同期大幅增长134.16%，彰显出强劲的销售增长动能。
从业务结构来看，2026年上半年，公司收入构成实现显著优化，战略重心已顺利从传统劳务服务领域转移至高附加值的医疗器械市场。其中，来自微创手术解决方案、医疗产品及相关服务费的综合收入占比已攀升至74.73%，成为支撑业绩增长的绝对主力。
继2025年医疗器械销售收益录得良好增长后，2026年上半年该项业务收益同比激增301.5%，达到2542.7万新加坡元，显示出充沛且可持续的增长潜力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.